FDA Inspection
Topharman Shandong Co., Ltd.Topharman Shandong Co., Ltd. – FDA Inspection, May 17, 2024
Record Details
This FDA Inspection record concerns Topharman Shandong Co., Ltd., with an inspection on May 17, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · dbeabf66-f709-4e81-8b78-f6699ec7bd18
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1241491
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Topharman Shandong Co., Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 28, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Topharman Shandong Co., Ltd.
- FDA Inspection 988743 - 2016-09-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.